Bisphosphonate treatment in primary breast cancer: Results from a randomised comparison of oral pamidronate versus no pamidronate in patients with primary breast cancerBent Bruun Kristensen, Jonas Bergh, Jørn Andersen et al.|Acta Oncologica|2008Cited by 71
The risk of amenorrhoea after adjuvant chemotherapy for early stage breast cancer is related to inter-individual variations in chemotherapy-induced leukocyte nadir in young patients: Data from the randomised SBG 2000-1 studyMikkel Rosendahl, Michael Andersson, Johan Ahlgren et al.|European Journal of Cancer|2009Cited by 21